Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2421

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-2421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement with labeled functional groups and the hydrochloride component.*

FDA Label Image

Image-02 (Image 02)

A scatter plot showing fold change and 90% confidence intervals for venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite pharmacokinetics (Cmax and AUC) across special populations. Populations include hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis measures change relative to a reference value.*

FDA Label Image

Image-03 (Image 03)

A scatter plot chart showing the fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of venlafaxine and its metabolite ODV when interacting with various drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole (in CYP2D6 EM's and PM's), Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis represents change relative to the reference value from 0 to 3, with data points indicating increases or decreases in pharmacokinetic metrics.*

FDA Label Image

Image-04 (Image 04)

A forest plot chart showing fold changes and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes when interacting with different drugs. The x-axis represents the change relative to the reference value, with data points and error bars for each analyte listed by interacting drug, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

FDA Label Image

Label (Lbl713352421)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 75 mg strength. The label indicates a package of 90 capsules, marked Rx only. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Teva Pharmaceuticals USA Inc. Storage instructions and warnings such as 'May Cause Drowsiness' are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.